Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000874015-25-000109
Filing Date
2025-04-16
Accepted
2025-04-16 17:41:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2750
  Complete submission text file 0000874015-25-000109.txt   4261
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Subject) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-19125 | Film No.: 25843728
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210
Business Address
Jenne Kyle (Reporting) CIK: 0001791857 (see all company filings)

Type: 144